Skip to main content
Clinical Trials/CTRI/2020/05/025416
CTRI/2020/05/025416
Not yet recruiting
未知

To study the efficacy of levetiracetam in comparison to phenobarbitone as a first line anticonvulsant for neonatal seizures in asphyxiated term babies.

Department of Neonatology0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Neonatology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Neonatology

Eligibility Criteria

Inclusion Criteria

  • All term asphyxiated babies born at our tertiary centre who satisfy WHO definition of asphyxia with seizures within 48 hours of life

Exclusion Criteria

  • Antenatal diagnosed cns malformation
  • Metabolic seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials